Revenue for the 4Q was 415.2M, FLAT compared to June 30/13 Q. EPS for the 4Q was $0.61, a 22% increase from the June 30/13 Q. Operating profit for the 4Q was $98.5 million, cash flow from operations - $115.6 million. 4Q results lower than anticipated, due to softer sales in the states, partially offset by growth in international markets. Good to see that they are gaining traction with AirFit platform and the launch of Astral platform looks OK. Flat result on a bad day in the market. Should see a re-rate upon launch of Airsense 10
On Resmed Inc (RMD) applies for coding for flow-generator platform -
Great article shoe.
On Are market conditions more supportive for Australian stocks - or overseas shares -
They had a big product redemption on the 27th of June of $173m US, their FUM grew from May to June which is a good sign of inflows & performance. Stock may cum upgrade for 2015+ earnings. Report on 19/08 Stock is likely cum-upgrade for 2015+ earnings. Result on 19/08